PMC:7652766 / 72964-73441
Annnotations
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T115 | 317-331 | Phenotype | denotes | cytokine storm | http://purl.obolibrary.org/obo/HP_0033041 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T357 | 0-84 | Sentence | denotes | Furthermore, some immunomodulatory mAbs have been tested in the context of COVID-19. |
T358 | 85-424 | Sentence | denotes | It is remarkable that until now most of the data published regarding the use of immunomodulatory mAbs derive from studies using either anti-IL-6 or anti-IL-6R, probably because using IL-6 blockers seems promising at controlling the cytokine storm associated with the development of ARDS in more aggressive patterns of SARS-CoV-2 infection. |
T359 | 425-477 | Sentence | denotes | However, clinical observations remain controversial. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2684 | 225-229 | Gene | denotes | IL-6 | Gene:3569 |
2685 | 238-243 | Gene | denotes | IL-6R | Gene:3570 |
2686 | 268-272 | Gene | denotes | IL-6 | Gene:3569 |
2687 | 75-83 | Disease | denotes | COVID-19 | MESH:C000657245 |
2688 | 367-371 | Disease | denotes | ARDS | MESH:D012128 |
2689 | 403-423 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |